why did fda stop tirzepatide says years-long shortage is resolved, will give limited leeway to compounders FDA Approves Tirzepatide (Zepbound) as

GLP-1 receptor agonists work by mimicking hormones naturally produced in your intestines, regulating blood sugar, slowing gastric emptying, and reducing appetite at the neurological level

The treatment course consisted of once-daily injections administered over five consecutive days, beginning 24 hours after the initial hydrazine injection [1]

2.2 Study design This study involved biomarker exploration and data mining derived from a previously conducted exploratory, randomized, controlled, open-label intervention trial (without a placebo arm) ( Figure 1 )

Circulation 117 , 32383249 (2008)

J Clin Endocrinol Metab 100(9):35653571